Back to Search
Start Over
Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians
- Source :
- International Journal of Chronic Obstructive Pulmonary Disease
- Publication Year :
- 2017
- Publisher :
- Dove Medical Press, 2017.
-
Abstract
- Airway mucus hypersecretion is a frequent symptom associated with acute and chronic airway disease. Inhibition of mucus production or promotion of mucolysis not only relieved symptoms but also improved disease outcomes. There are numerous available mucoactive medicines for prescription, and how to select them properly for different diseases is important for clinical practice. So far, there is no one consensus or guideline reported. A group of Chinese pulmonary physicians worked together to complete this consensus based on literature review, summarized mechanism and usage of each classical mucoactive medicine. In general, antioxidant mucoactive medicines play an important role in chronic airway disease, including but not limited to airway mucus clearance, reduced acute exacerbation and improved pulmonary function.
- Subjects :
- 0301 basic medicine
030213 general clinical medicine
Chronic bronchitis
medicine.medical_specialty
China
Consensus
Exacerbation
Review
Antioxidants
Pulmonary function testing
03 medical and health sciences
Pulmonary Disease, Chronic Obstructive
0302 clinical medicine
medicine
Humans
Medical prescription
Intensive care medicine
Lung
Expectorants
COPD
business.industry
sputum
General Medicine
Guideline
Recovery of Function
respiratory system
medicine.disease
mucolysis
Mucus
030104 developmental biology
Pulmonologists
Treatment Outcome
Mucociliary Clearance
Disease Progression
Quality of Life
Sputum
chronic bronchitis
medicine.symptom
business
Airway
Subjects
Details
- Language :
- English
- ISSN :
- 11782005 and 11769106
- Volume :
- 12
- Database :
- OpenAIRE
- Journal :
- International Journal of Chronic Obstructive Pulmonary Disease
- Accession number :
- edsair.doi.dedup.....418eb0c3d54f6577019129ccf9624111